Literature DB >> 9825481

Human somatostatin receptor mediated antiproliferative action evokes subtype selective cytotoxic and cytostatic signaling.

C B Srikant1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9825481      PMCID： PMC2589268     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


× No keyword cloud information.
  30 in total

1.  In situ dephosphorylation of p53 protein by calf intestinal alkaline phosphatase treatment.

Authors:  D A Baunoch; M Xu; A Tewari; J K Christman; M A Lane
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

2.  Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells.

Authors:  K Sharma; C B Srikant
Journal:  Int J Cancer       Date:  1998-04-13       Impact factor: 7.396

3.  Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies.

Authors:  P M Smith-Jones; B Stolz; C Bruns; R Albert; H W Reist; R Fridrich; H R Mäcke
Journal:  J Nucl Med       Date:  1994-02       Impact factor: 10.057

4.  G protein activation of a hormone-stimulated phosphatase in human tumor cells.

Authors:  M G Pan; T Florio; P J Stork
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

5.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

6.  Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

Authors:  E P Krenning; W H Bakker; P P Kooij; W A Breeman; H Y Oei; M de Jong; J C Reubi; T J Visser; C Bruns; D J Kwekkeboom
Journal:  J Nucl Med       Date:  1992-05       Impact factor: 10.057

7.  Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.

Authors:  J F Bruno; Y Xu; M Berelowitz
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

8.  Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line.

Authors:  M T Hierowski; C Liebow; K du Sapin; A V Schally
Journal:  FEBS Lett       Date:  1985-01-07       Impact factor: 4.124

9.  Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue.

Authors:  H Huynh; M Pollak
Journal:  Biochem Biophys Res Commun       Date:  1994-08-30       Impact factor: 3.575

10.  Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype.

Authors:  Y C Patel; R Panetta; E Escher; M Greenwood; C B Srikant
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157
View more
  3 in total

1.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

2.  The immunohistochemical localisation of somatostatin receptors 1, 2, 3, and 5 in acoustic neuromas.

Authors:  N D Stafford; L T Condon; M J C Rogers; L Helboe; D A Crooks; S L Atkin
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

3.  Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours.

Authors:  G H Hall; L W Turnbull; I Richmond; L Helboe; S L Atkin
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.